Nancy Chan
Impact in
- Oncology top 5%
- Cancer Immunotherapy and Biomarkers
- HER2/EGFR in Cancer Research
- Cancer Research top 10%
- Breast Cancer Treatment Studies
Papers in
- Oncology 18
- Cancer Immunotherapy and Biomarkers 8
- PARP inhibition in cancer therapy 4
- HER2/EGFR in Cancer Research 3
-
- Breast Cancer Treatment Studies 7
- Co-authors
- Shridar Ganesan (5 shared papers)Jyoti Dhar Malhotra (6 shared papers)Janice M. Mehnert (5 shared papers)Salma K. Jabbour (2 shared papers)Kristen Renee Spencer (3 shared papers)Eugenia Girda (4 shared papers)Ann Willman Silk (3 shared papers)Alexandre Buckley de Meritens (2 shared papers)
- Journals
- Clinical Cancer Research (4 papers)Gynecologic Oncology (2 papers)Journal for ImmunoTherapy of Cancer (2 papers)Annals of Oncology (2 papers)npj Breast Cancer (2 papers)
- Partner nations
- United StatesSpainAustralia
In The Last Decade
Nancy Chan
31 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 68
- Oncology 453
- Cancer Research 194
- Genetics 81
- Pulmonary and Respiratory Medicine 217
- Nutrition and Dietetics 84
Countries citing papers authored by Nancy Chan
This map shows the geographic impact of Nancy Chan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nancy Chan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nancy Chan more than expected).
Fields of papers citing papers by Nancy Chan
This network shows the impact of papers produced by Nancy Chan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nancy Chan. The network helps show where Nancy Chan may publish in the future.
Co-authors
The 25 scholars most cited alongside Nancy Chan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 32 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2021 | 239 | |
| 2 | 2019 | 216 | |
| 3 | 2016 | 209 | |
| 4 | 2017 | 182 | |
| 5 | 2017 | 132 | |
| 6 | 2020 | 83 | |
| 7 | 2019 | 60 | |
| 8 | 2022 | 25 | |
| 9 | 2022 | 21 | |
| 10 | 2018 | 20 | |
| 11 | 2020 | 20 | |
| 12 | 2020 | 16 | |
| 13 | 2021 | 15 | |
| 14 | 2016 | 14 | |
| 15 | 2022 | 14 | |
| 16 | 2022 | 12 | |
| 17 | 2016 | 11 | |
| 18 | 2021 | 11 | |
| 19 | 2022 | 11 | |
| 20 | 2024 | 9 |
About Nancy Chan
Nancy Chan is a scholar working on Oncology, Cancer Research, Genetics, Reproductive Medicine and Radiology, Nuclear Medicine and Imaging, having authored 32 papers that have together received 1.4k indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (8 papers), Breast Cancer Treatment Studies (7 papers), PARP inhibition in cancer therapy (4 papers), Monoclonal and Polyclonal Antibodies Research (3 papers), HER2/EGFR in Cancer Research (3 papers), Lung Cancer Treatments and Mutations (2 papers), Nanoparticle-Based Drug Delivery (2 papers) and Glioma Diagnosis and Treatment (2 papers). The work is most often cited by research in Oncology (453 citations), Cancer Research (194 citations), Genetics (81 citations), Pulmonary and Respiratory Medicine (217 citations) and Nutrition and Dietetics (84 citations). Nancy Chan has collaborated with scholars based in United States, Spain and Australia. Frequent co-authors include Shridar Ganesan, Jyoti Dhar Malhotra, Janice M. Mehnert, Salma K. Jabbour, Kristen Renee Spencer, Eugenia Girda, Ann Willman Silk, Alexandre Buckley de Meritens, Roman Groisberg and Aliza Leiser. Their work appears in journals such as Clinical Cancer Research, Gynecologic Oncology, Journal for ImmunoTherapy of Cancer, Annals of Oncology and npj Breast Cancer.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.